CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 94 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $292,000 | -63.9% | 58,500 | -8.6% | 0.00% | -100.0% |
| Q4 2020 | $809,000 | +26.4% | 63,973 | -1.8% | 0.00% | 0.0% |
| Q3 2020 | $640,000 | +1.4% | 65,173 | +2.8% | 0.00% | 0.0% |
| Q2 2020 | $631,000 | -5.7% | 63,373 | -16.3% | 0.00% | 0.0% |
| Q1 2020 | $669,000 | -38.6% | 75,689 | -35.9% | 0.00% | 0.0% |
| Q4 2019 | $1,089,000 | +19.9% | 118,100 | -23.6% | 0.00% | 0.0% |
| Q3 2019 | $908,000 | -48.2% | 154,500 | +5.8% | 0.00% | -50.0% |
| Q2 2019 | $1,752,000 | -2.6% | 146,000 | -2.1% | 0.00% | 0.0% |
| Q1 2019 | $1,799,000 | +60.6% | 149,079 | +67.0% | 0.00% | 0.0% |
| Q4 2018 | $1,120,000 | -10.7% | 89,279 | +5.7% | 0.00% | 0.0% |
| Q3 2018 | $1,254,000 | -15.4% | 84,479 | -4.1% | 0.00% | 0.0% |
| Q2 2018 | $1,482,000 | -23.9% | 88,079 | +3.6% | 0.00% | -33.3% |
| Q1 2018 | $1,947,000 | -11.5% | 85,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $2,199,000 | +75.4% | 85,000 | 0.0% | 0.00% | +50.0% |
| Q3 2017 | $1,254,000 | +5.7% | 85,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,186,000 | -18.2% | 85,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $1,450,000 | +65.7% | 85,000 | 0.0% | 0.00% | +100.0% |
| Q4 2016 | $875,000 | +1.9% | 85,000 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $859,000 | -10.1% | 85,000 | 0.0% | 0.00% | -50.0% |
| Q2 2016 | $955,000 | -17.7% | 85,000 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $1,161,000 | -41.0% | 85,000 | -18.0% | 0.00% | -33.3% |
| Q4 2015 | $1,967,000 | +23.3% | 103,700 | +22.0% | 0.00% | 0.0% |
| Q3 2015 | $1,595,000 | +26.0% | 85,000 | 0.0% | 0.00% | +50.0% |
| Q2 2015 | $1,266,000 | +7.2% | 85,000 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $1,181,000 | 0.0% | 85,000 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $1,181,000 | +10.2% | 85,000 | 0.0% | 0.00% | +100.0% |
| Q3 2014 | $1,072,000 | +24.8% | 85,000 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $859,000 | -15.8% | 85,000 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $1,020,000 | – | 85,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 4,420,349 | $25,814,838 | 3.96% |
| Parkman Healthcare Partners LLC | 1,203,484 | $7,028,347 | 1.87% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,002,783 | $5,856,253 | 1.26% |
| TANG CAPITAL MANAGEMENT LLC | 1,150,000 | $6,716,000 | 0.98% |
| BVF INC/IL | 3,629,000 | $21,193,360 | 0.89% |
| Nantahala Capital Management | 1,732,388 | $10,117,146 | 0.66% |
| AWM Investment Company, Inc. | 666,661 | $3,893,300 | 0.56% |
| INGALLS & SNYDER LLC | 1,295,833 | $7,568 | 0.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 200,800 | $1,172,672 | 0.36% |
| Kensington Investment Counsel, LLC | 58,599 | $342,218 | 0.27% |